Title : Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice - Attia_2023_Mutat.Res.Genet.Toxicol.Environ.Mutagen_892_503707 |
Author(s) : Attia SM , Ahmad SF , Nadeem A , Attia MSM , Ansari MA , Ashour AE , Albekairi NA , Al-Hamamah MA , Alshamrani AA , Bakheet SA |
Ref : Mutat Res Genet Toxicol Environ Mutagen , 892 :503707 , 2023 |
Abstract : Attia_2023_Mutat.Res.Genet.Toxicol.Environ.Mutagen_892_503707 |
ESTHER : Attia_2023_Mutat.Res.Genet.Toxicol.Environ.Mutagen_892_503707 |
PubMedSearch : Attia_2023_Mutat.Res.Genet.Toxicol.Environ.Mutagen_892_503707 |
PubMedID: 37973297 |
Attia SM, Ahmad SF, Nadeem A, Attia MSM, Ansari MA, Ashour AE, Albekairi NA, Al-Hamamah MA, Alshamrani AA, Bakheet SA (2023)
Saxagliptin, a selective dipeptidyl peptidase-4 inhibitor, alleviates somatic cell aneugenicity and clastogenicity in diabetic mice
Mutat Res Genet Toxicol Environ Mutagen
892 :503707
Attia SM, Ahmad SF, Nadeem A, Attia MSM, Ansari MA, Ashour AE, Albekairi NA, Al-Hamamah MA, Alshamrani AA, Bakheet SA (2023)
Mutat Res Genet Toxicol Environ Mutagen
892 :503707